Latest Interviews
"In light of the pandemic, many companies have been facing challenges with the inter-Latam supply chains, mainly due to constraints on capacity and container availability for ocean shipments. This reality drove companies to look for land transportation alternatives to ship their goods around the continent."
58427
“The savings made in other health services thanks to medicines could be used to finance pharmaceutical spending. We need a new model, one no longer simply focused on containing costs, but oriented towards access to all available therapies.”
58425
"We focus on these areas because we can help a large population of patients who do not have access to any treatments."
58386
"We are focused on improving the uptime of our products by focusing on strengthening the company’s client-attention capabilities and prioritizing the incorporation of technology."
58420
"The new LGM Pharma offers end-to-end services and unique partnerships so clients do not have to worry about supply chain, regulatory, and manufacturing scale up."
58418
"Our side-effect blocking drugs like TK-90 make existing cancer treatments safer and more effective. We see this process continuing in cancer therapy, and we intend to be part of it."